Make an Appointment: (682) 265-7287 |   [email protected]

  • Exploring Ayahuasca: The Amazonian Brew with a Twist of Potential

    In recent years, Ayahuasca has stealthily woven its way into the cultural fabric of the United States, blending indigenous traditions with contemporary curiosity. Initially confined to the depths of the Amazon rainforest, Ayahuasca’s journey to the U.S. has been facilitated by a growing global interest in alternative healing practices and consciousness exploration. This psychedelic potion, brewed from a tag team of plants, Banisteriopsis caapi and Psychotria viridis. (1) The United States is slowly waking up to its existence, with a curious blend of skepticism and fascination.

    From Jungle Rituals to U.S. Courtrooms

    Traditionally, Ayahuasca has been sipped during indigenous rituals in the Amazon. The brew’s introduction to the U.S. gained momentum through legal and religious channels. Notably, the U.S. Supreme Court has granted approval for the religious use of Ayahuasca by certain groups, such as União do Vegetal and Santo Daime. Despite this legal green light, the Schedule I status of DMT, a key component of Ayahuasca, has curtailed clinical trials in the U.S., leaving its therapeutic potential in a liminal space. Nonetheless, as the intrigue surrounding Ayahuasca continues to percolate through various communities, it sparks a conversation about the intersection of ancient plant wisdom and modern consciousness exploration within the diverse landscapes of the United States.

    Ayahuasca and Psychosis

    Ayahuasca-induced psychoses have been documented, especially in individuals with a history of mood disorders, psychotic disorders, or substance use. These episodes can manifest as altered perceptions of reality, hallucinations, and disorganized thinking. It’s important to note that these Ayahuasca-induced psychoses are typically not prolonged, and the effects tend to subside as the brew’s influence wanes. Screening individuals for preexisting psychiatric disorders has been suggested as a method to mitigate these psychoses, but the available data on this matter is derived from relatively small sample sizes, limiting generalizability.

    As Ayahuasca gains popularity beyond traditional Amazonian rituals, understanding and addressing the potential risks, including the occurrence of psychosis, becomes crucial. While many users describe positive and transformative experiences with Ayahuasca, it underscores the importance of responsible and informed use, especially for individuals with a history of mental health issues. As with any powerful psychedelic substance, the impact of Ayahuasca on an individual’s mental state is complex and varies widely, making careful consideration and preparation essential. (2)

    Ayahuasca and Depression

    Now, let’s talk about the intriguing side of Ayahuasca – its potential therapeutic effects, particularly in the realm of depression. In a small clinical trial conducted in Brazil, researchers found that Ayahuasca had a significant impact on patients with depression who had not responded to traditional antidepressants. Picture this: a standard dose of Ayahuasca led to a 62% reduction in depressive symptoms just one day after consumption. The effects were even more pronounced at the seven-day mark, with a 72% reduction. It’s like a mental health reset button with a twist of Amazonian magic. (3)

    Replicating the Magic

    Not satisfied with just a sneak peek, the researchers decided to up the ante with a larger sample of 17 participants. The results echoed the initial findings – a significant decrease in depressive symptoms starting just 80 minutes after sipping on the Ayahuasca cocktail. At the 21-day follow-up, participants were riding the wave of a highly statistically significant mean change in their depressive scores. However, it’s essential to sprinkle a bit of skepticism on these findings as the studies weren’t randomized, double-blinded, or placebo-controlled. (4)

    A Pleasant Trip with a Dash of Vomiting

    Imagine sipping on a potion that takes you on a journey through altered realities and mystical dimensions. Ayahuasca, when consumed, unleashes a symphony of effects on the mind and body. While half the participants experienced a not-so-pleasant side effect of vomiting, most described the Ayahuasca session as an overall positive experience. No serious adverse events were observed, proving that the Amazonian brew might be a bumpy ride, but it’s not a dangerous one.

    The Amazonian Conundrum

    Despite the promising therapeutic signals, the data on Ayahuasca’s clinical use is as murky as the brew itself. Several factors, including the lack of chemical analyses to confirm the exact ingredients in Ayahuasca, cast a shadow over the studies. The concoction served in these trials was far from standardized, with indigenous preparations boasting additional compounds like caffeine, nicotine, cocaine, and scopolamine. To truly unlock Ayahuasca’s therapeutic potential, the scientific community needs to embark on randomized clinical trials using pharmacologically pure compounds if we want to legalize the substance for therapeutic purposes.

    Disclaimer: Psychedelic Assisted Psychotherapy has not been approved by any regulatory agencies in the United States, and the safety and efficacy are still not formally established at the time of this writing.

    1. McKenna D, Riba J: New World tryptamine hallucinogens and the neuroscience of ayahuasca, in Behavioral Neurobiology of Psychedelic Drugs. Edited by Halberstadt AL, Vollenweider FX, Nichols DE. Berlin, Heidelberg, Springer, 2018, pp 283–311

    2. Dos Santos RG, Bouso JC, Hallak JEC: Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Ther Adv Psychopharmacol 2017; 7:141–157

    3. Osório FdeL, Sanches RF, Macedo LR, et al: Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Br J Psychiatry 2015; 37:13–20

    4. Sanches RF, de Lima Osório F, Dos Santos RG, et al: Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol 2016; 36:77–8